UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diversity and collaboration

THE JOURNAL OF THE ACOUSTICAL SOCIETY OF JAPAN, 2023/10/01, Vol.79(10), pp.493-494

Imaizumi, Satoshi

2023

Volltextzugriff (PDF)

Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality: VN-SEESAW-HDL

Circulation Journal, 2014/11/25, Vol.78(12), pp.2955-2962

2014

Volltextzugriff (PDF)

Pressure-Induced Superconductivity in Iron-Based Spin-Ladder Compound BaFe2+δ(S1−xSex)3

Materials, 2022-02, Vol.15 (4), p.1401

2022

Volltextzugriff (PDF)

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (46), p.19997-20002

2010

Volltextzugriff (PDF)

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide

International journal of cardiology, 2019-12, Vol.297, p.111-117

2019

Volltextzugriff (PDF)

Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice

International journal of cardiology, 2016-10, Vol.220, p.602-607

2016

Volltextzugriff (PDF)

Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis

Biomolecules (Basel, Switzerland), 2023-08, Vol.13 (9), p.1278

2023

Volltextzugriff (PDF)

Simulation-based evaluation of energy efficiency for millimeter-wave network

IEICE COMMUNICATIONS EXPRESS, 2022-12, Vol.11 (12), p.823-828, Article 2022COL0038

2022

Volltextzugriff (PDF)

HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer

Molecular cancer therapeutics, 2012-06, Vol.11 (6), p.1311-1319

2012

Volltextzugriff (PDF)

Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation

EMBO reports, 2008-02, Vol.9 (2), p.179-186

2008

Volltextzugriff (PDF)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]

Journal of lipid research, 2011-06, Vol.52 (6), p.1200-1210

2011

Volltextzugriff (PDF)

Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors

Current pharmaceutical design, 2013, Vol.19 (17), p.2981-2987

2013

Volltextzugriff (PDF)

Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers

Current pharmaceutical design, 2013, Vol.19 (17), p.3002-3008

2013

Volltextzugriff (PDF)

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

The Journal of biological chemistry, 2006-07, Vol.281 (28), p.19288-19295

2006

Volltextzugriff (PDF)

Auditory Verbal Cues Alter the Perceived Flavor of Beverages and Ease of Swallowing: A Psychometric and Electrophysiological Analysis

BioMed research international, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Chymase inhibitors

Current pharmaceutical design, 2013, Vol.19 (17), p.3065-3071

2013

Volltextzugriff (PDF)

Effects of smoking cessation on HDL functionality

Tobacco induced diseases, 2019-10, Vol.17 (1)

2019

Volltextzugriff (PDF)

Frequent Premature Ventricular Complexes Originating from the Left Ventricular Summit Successfully Ablated from the Proximal Great Cardiac Vein Using an Impedance-based Electroanatomical Mapping System

Internal Medicine, 2016/07/01, Vol.55(13), pp.1751-1753

2016

Volltextzugriff (PDF)

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

Circulation Journal, 2011, Vol.75(7), pp.1533-1538

2011

Volltextzugriff (PDF)

Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo

International journal of cardiology, 2015-08, Vol.192, p.82-88

2015

Volltextzugriff (PDF)

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice

Journal of the American Heart Association, 2013-06, Vol.2 (3), p.e000048-n/a

2013

Volltextzugriff (PDF)

Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor

PloS one, 2012-06, Vol.7 (6), p.e37974-e37974

2012

Volltextzugriff (PDF)

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation

Journal of cardiology, 2016-12, Vol.68 (6), p.529-535

2016

Volltextzugriff (PDF)

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

International journal of cardiology, 2016-03, Vol.207, p.317-325

2016

Volltextzugriff (PDF)

1 – 25 von 557

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(455)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Diversity and collaboration

Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality: VN-SEESAW-HDL

Pressure-Induced Superconductivity in Iron-Based Spin-Ladder Compound BaFe2+δ(S1−xSex)3

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide

Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice

Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis

Simulation-based evaluation of energy efficiency for millimeter-wave network

HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer

Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]

Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors

Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

Auditory Verbal Cues Alter the Perceived Flavor of Beverages and Ease of Swallowing: A Psychometric and Electrophysiological Analysis

Chymase inhibitors

Effects of smoking cessation on HDL functionality

Frequent Premature Ventricular Complexes Originating from the Left Ventricular Summit Successfully Ablated from the Proximal Great Cardiac Vein Using an Impedance-based Electroanatomical Mapping System

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo

FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

Aktive Filter

Suchergebnisse filtern